ArticleBlood advances2022

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.

Meghan C Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.